CNBX Pharmaceuticals Inc.
CNBX
$0.0023
$0.000315.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -295.40K | -551.10K | -695.20K | -1.21M | -1.23M |
| Total Depreciation and Amortization | 0.00 | 32.90K | 72.40K | 110.90K | 150.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.30K | 202.10K | 245.40K | 622.10K | 657.10K |
| Change in Net Operating Assets | 114.30K | 104.60K | 133.20K | 299.70K | 230.00K |
| Cash from Operations | -138.90K | -211.60K | -244.30K | -175.50K | -194.30K |
| Capital Expenditure | 0.00 | 0.00 | -1.20K | -1.20K | -1.20K |
| Sale of Property, Plant, and Equipment | 94.70K | 114.70K | 114.70K | 114.70K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | 94.70K | 114.70K | 113.50K | 113.50K | 18.80K |
| Total Debt Issued | 112.60K | 32.60K | 27.60K | 91.30K | 105.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 112.60K | 32.60K | 27.60K | 91.30K | 105.00K |
| Foreign Exchange rate Adjustments | -59.90K | 0.00 | 0.00 | 0.00 | 59.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.50K | -64.30K | -103.20K | 29.30K | -10.60K |